-
CDC: Reported Measles Cases Reach 971
drugs
June 03, 2019
Reported Measles Cases Reach 971.
-
U.S. Measles Cases for 2019 Already Exceed All Annual Totals Since 1994: CDC
drugs
May 31, 2019
U.S. Measles Cases for 2019 Already Exceed All Annual Totals Since 1994: CDC.
-
GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China
fiercepharma
May 29, 2019
GlaxoSmithKline’s shingles vaccine Shingrix has continuously impressed industry watchers with its explosive growth. Now, the company has added another large market to its list: China.
-
California Bill to Tighten Vaccine Exemptions Moves Forward
drugs
May 24, 2019
California Bill to Tighten Vaccine Exemptions Moves Forward.
-
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
drugs
May 22, 2019
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial.
-
WuXi Biologics signs vaccine manufacturing contract
biospectrumasia
May 21, 2019
WuXi Vaccines is a joint venture company to be established between WuXi Biologics and Shanghai based Hile Bio-Technology.
-
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
En-CPhI.cn
May 21, 2019
WuXi Biologics announced that it has entered into a strategic partnership Letter of Intent (LOI) with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.
-
Ghana launches the world’s largest vaccine drone delivery network
europeanpharmaceuticalreview
May 15, 2019
Gavi, the Vaccine Alliance has announced support for the expansion of a medical drone network into Ghana.
-
New MenB awareness drive backs up vaccine makers GSK, Pfizer
fiercepharma
May 06, 2019
Meningitis B vaccine makers GlaxoSmithKline and Pfizer have been running awareness campaigns for years, yet vaccination rates remain stagnant.
-
Sanofi’s dengue vaccine secures FDA approval
pharmaceutical-technology
May 06, 2019
Sanofi has received approval from the US Food and Drug Administration (FDA) for Dengvaxia, a vaccine that is designed to prevent all four dengue disease serotypes.